Long-term follow-up of a quadrivalent HPV vaccine

  • Lambert J
  • 15


    Mendeley users who have this article in their library.
  • 0


    Citations of this article.


Human papillomavirus (HPV) infection causes genital warts and cervical cancers. A number of preventive HPV vaccines have been developed. Follow-up of patients who were enrolled in initial efficacy trials of these vaccines is ongoing. Such trials have proven HPV vaccines to be effective in preventing persistent infection and cervical disease; however, long-term safety, efficacy and immunogenicity can only be ascertained by longer-term follow-up. At 5 years' follow-up, the prophylactic quadrivalent HPV vaccine targeting HPV 6/11/16/18 demonstrates an excellent safety profile and continues to prevent persistent infection and disease. The need for booster immunizations continues to be under review. (copyright) 2007 Future Drugs Ltd.

Author-supplied keywords

  • Cervical cancer prevention
  • Human papillomavirus
  • Prevention of genital warts
  • Vaccine

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • John S. Lambert

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free